NBIX logo

Neurocrine Biosciences (NBIX) Cost Of Goods Sold

Annual Cost Of Goods Sold

$39.70 M
+$16.50 M+71.12%

31 December 2023

1-Year Change

+71.12%
NBIX annual cost of goods sold is up +71.12% year-on-year

3-Year Change

+293.07%
NBIX annual cost of goods sold is up +293.07% over the past 3 years

All-time High

$39.70 M
NBIX annual cost of goods sold is currently at an all-time high

Sector Rank

50.81%
NBIX annual cost of goods sold is higher than 50.81% of companies in Healthcare sector
Annual Revenue$1.89 B
NBIX annual revenue is $1.89 billion
Annual Gross Profit$1.85 B
NBIX annual gross profit is $1.85 billion
Annual Operating Profit$394.80 M
NBIX annual operaing income is $394.80 million
Annual Net Income$249.70 M
NBIX annual net profit is $249.70 million

NBIX Cost Of Goods Sold Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Cost Of Goods Sold

$8.00 M
-$1.20 M-13.04%

30 September 2024

1-Year Change

-28.57%
NBIX quarterly cost of goods sold is down -28.57% year-on-year

3-Year Change

+90.48%
NBIX quarterly cost of goods sold is up +90.48% over the past 3 years

All-time High

$11.50 M
NBIX quarterly cost of goods sold is currently -30.43% below its historical high of $11.50 million

Sector Rank

43.46%
NBIX quarterly cost of goods sold is higher than 43.46% of companies in Healthcare sector
Quarterly Revenue$622.10 M
NBIX quarterly revenue is $622.10 million
Quarterly Gross Profit$614.10 M
NBIX quarterly gross profit is $614.10 million
Quarterly Operating Profit$184.80 M
NBIX quarterly operating income is $184.80 million
Quarterly Net Income$129.80 M
NBIX quarterly net profit is $129.80 million

NBIX Quarterly Cost Of Goods Sold Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Cost Of Goods Sold

$33.20 M
-$3.20 M-8.79%

30 September 2024

1-Year Change

-14.65%
NBIX TTM cost of goods sold is down -14.65% year-on-year

3-Year Change

+153.44%
NBIX TTM cost of goods sold is up +153.44% over the past 3 years

All-time High

$39.70 M
NBIX TTM cost of goods sold is currently -16.37% below its historical high of $39.70 million

Sector Rank

44.55%
NBIX TTM cost of goods sold is higher than 44.55% of companies in Healthcare sector
TTM Revenue$2.24 B
NBIX TTM revenue is $2.24 billion
TTM Gross Profit$2.21 B
NBIX TTM gross profit is $2.21 billion
TTM Operating Profit$588.30 M
NBIX TTM operating income is $588.30 million
TTM Net Income$385.90 M
NBIX TTM net profit is $385.90 million

NBIX TTM Cost Of Goods Sold Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NBIX Cost Of Goods Sold Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+71.1%-28.6%-14.7%
3 y3 years+293.1%+90.5%+153.4%
5 y5 years+710.2%+263.6%+415.1%

NBIX Cost Of Goods Sold High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+293.1%-30.4%+95.1%-16.4%+153.4%
5 y5 yearsat high+710.2%-30.4%+280.9%-16.4%+415.1%
alltimeall timeat high+1906.2%-30.4%+1433.3%-16.4%+1596.8%

Neurocrine Biosciences Cost Of Goods Sold History

DateAnnualQuarterlyTTM
Sept 2024
-
$8.00 M(-13.0%)
$33.20 M(-8.8%)
June 2024
-
$9.20 M(+22.7%)
$36.40 M(-5.9%)
Mar 2024
-
$7.50 M(-11.8%)
$38.70 M(-2.5%)
Dec 2023
$39.70 M(+71.1%)
$8.50 M(-24.1%)
$39.70 M(+2.1%)
Sept 2023
-
$11.20 M(-2.6%)
$38.90 M(+15.1%)
June 2023
-
$11.50 M(+35.3%)
$33.80 M(+24.7%)
Mar 2023
-
$8.50 M(+10.4%)
$27.10 M(+16.8%)
Dec 2022
$23.20 M(+62.2%)
$7.70 M(+26.2%)
$23.20 M(+18.4%)
Sept 2022
-
$6.10 M(+27.1%)
$19.60 M(+10.7%)
June 2022
-
$4.80 M(+4.3%)
$17.70 M(+10.6%)
Mar 2022
-
$4.60 M(+12.2%)
$16.00 M(+11.9%)
Dec 2021
$14.30 M(+41.6%)
$4.10 M(-2.4%)
$14.30 M(+9.2%)
Sept 2021
-
$4.20 M(+35.5%)
$13.10 M(+12.9%)
June 2021
-
$3.10 M(+6.9%)
$11.60 M(+6.4%)
Mar 2021
-
$2.90 M(0.0%)
$10.90 M(+7.9%)
Dec 2020
$10.10 M(+36.5%)
$2.90 M(+7.4%)
$10.10 M(+4.1%)
Sept 2020
-
$2.70 M(+12.5%)
$9.70 M(+5.4%)
June 2020
-
$2.40 M(+14.3%)
$9.20 M(+9.5%)
Mar 2020
-
$2.10 M(-16.0%)
$8.40 M(+13.5%)
Dec 2019
$7.40 M(+51.0%)
$2.50 M(+13.6%)
$7.40 M(+14.8%)
Sept 2019
-
$2.20 M(+37.5%)
$6.45 M(+11.2%)
June 2019
-
$1.60 M(+45.5%)
$5.80 M(+14.8%)
Mar 2019
-
$1.10 M(-28.8%)
$5.05 M(+3.1%)
Dec 2018
$4.90 M
$1.54 M(-0.4%)
$4.90 M(+19.1%)
Sept 2018
-
$1.55 M(+81.6%)
$4.12 M(+37.3%)
DateAnnualQuarterlyTTM
June 2018
-
$854.00 K(-10.1%)
$3.00 M(+36.0%)
Mar 2018
-
$950.00 K(+25.0%)
$2.20 M(+75.8%)
Dec 2017
$1.25 M(-157.1%)
$760.00 K(+75.5%)
$1.25 M(+153.8%)
Sept 2017
-
$433.00 K(+609.8%)
$494.00 K(+709.8%)
June 2017
-
$61.00 K(-110.5%)
$61.00 K(-102.8%)
Dec 2000
-$2.20 M(+4.7%)
-$580.00 K(+3.0%)
-$2.20 M(-0.9%)
Sept 2000
-
-$563.00 K(+5.0%)
-$2.22 M(+2.9%)
June 2000
-
-$536.00 K(+3.3%)
-$2.15 M(+6.7%)
Mar 2000
-
-$519.00 K(-13.5%)
-$2.02 M(-3.9%)
Dec 1999
-$2.10 M(+23.5%)
-$600.00 K(+20.0%)
-$2.10 M(+10.5%)
Sept 1999
-
-$500.00 K(+25.0%)
-$1.90 M(0.0%)
June 1999
-
-$400.00 K(-33.3%)
-$1.90 M(0.0%)
Mar 1999
-
-$600.00 K(+50.0%)
-$1.90 M(+11.8%)
Dec 1998
-$1.70 M(+30.8%)
-$400.00 K(-20.0%)
-$1.70 M(0.0%)
Sept 1998
-
-$500.00 K(+25.0%)
-$1.70 M(+13.3%)
June 1998
-
-$400.00 K(0.0%)
-$1.50 M(+7.1%)
Mar 1998
-
-$400.00 K(0.0%)
-$1.40 M(+16.7%)
Dec 1997
-$1.30 M(+30.0%)
-$400.00 K(+33.3%)
-$1.20 M(+9.1%)
Sept 1997
-
-$300.00 K(0.0%)
-$1.10 M(0.0%)
June 1997
-
-$300.00 K(+50.0%)
-$1.10 M(+10.0%)
Mar 1997
-
-$200.00 K(-33.3%)
-$1.00 M(0.0%)
Dec 1996
-$1.00 M
-$300.00 K(0.0%)
-$1.00 M(+42.9%)
Sept 1996
-
-$300.00 K(+50.0%)
-$700.00 K(+75.0%)
June 1996
-
-$200.00 K(0.0%)
-$400.00 K(+100.0%)
Mar 1996
-
-$200.00 K
-$200.00 K

FAQ

  • What is Neurocrine Biosciences annual cost of goods sold?
  • What is the all time high annual cost of goods sold for Neurocrine Biosciences?
  • What is Neurocrine Biosciences annual cost of goods sold year-on-year change?
  • What is Neurocrine Biosciences quarterly cost of goods sold?
  • What is the all time high quarterly cost of goods sold for Neurocrine Biosciences?
  • What is Neurocrine Biosciences quarterly cost of goods sold year-on-year change?
  • What is Neurocrine Biosciences TTM cost of goods sold?
  • What is the all time high TTM cost of goods sold for Neurocrine Biosciences?
  • What is Neurocrine Biosciences TTM cost of goods sold year-on-year change?

What is Neurocrine Biosciences annual cost of goods sold?

The current annual cost of goods sold of NBIX is $39.70 M

What is the all time high annual cost of goods sold for Neurocrine Biosciences?

Neurocrine Biosciences all-time high annual cost of goods sold is $39.70 M

What is Neurocrine Biosciences annual cost of goods sold year-on-year change?

Over the past year, NBIX annual cost of goods sold has changed by +$16.50 M (+71.12%)

What is Neurocrine Biosciences quarterly cost of goods sold?

The current quarterly cost of goods sold of NBIX is $8.00 M

What is the all time high quarterly cost of goods sold for Neurocrine Biosciences?

Neurocrine Biosciences all-time high quarterly cost of goods sold is $11.50 M

What is Neurocrine Biosciences quarterly cost of goods sold year-on-year change?

Over the past year, NBIX quarterly cost of goods sold has changed by -$3.20 M (-28.57%)

What is Neurocrine Biosciences TTM cost of goods sold?

The current TTM cost of goods sold of NBIX is $33.20 M

What is the all time high TTM cost of goods sold for Neurocrine Biosciences?

Neurocrine Biosciences all-time high TTM cost of goods sold is $39.70 M

What is Neurocrine Biosciences TTM cost of goods sold year-on-year change?

Over the past year, NBIX TTM cost of goods sold has changed by -$5.70 M (-14.65%)